Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Treasury Shares (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Treasury Shares for 4 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 9.84% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 9.84% year-over-year, with the annual reading at $2.3 million for FY2025, 9.84% up from the prior year.
  • Treasury Shares for Q4 2025 was $2.3 million at Orchestra BioMed Holdings, down from $2.6 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.9 million in Q1 2023, with the low at $49237.0 in Q2 2023.
  • Average Treasury Shares over 4 years is $1.9 million, with a median of $2.1 million recorded in 2024.
  • Peak annual rise in Treasury Shares hit 4928.3% in 2024, while the deepest fall reached 56.95% in 2024.
  • Over 4 years, Treasury Shares stood at $158589.0 in 2022, then soared by 972.72% to $1.7 million in 2023, then rose by 23.12% to $2.1 million in 2024, then grew by 9.84% to $2.3 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.3 million, $2.6 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.